Novo Nordisk A/S (NVO) intrinsic value

Price $37.32 on 2026-10-05.

MethodValueMargin of safety
DCF – bear case$219.80
DCF – base case$343.91+821.5%
DCF – bull case$469.63
Graham Number$26.65-40.0%

WACC 5.5%, revenue growth 2.1%, FCF margin 11.4%, EPS $4.09, book value per share $7.72. 3 valuation runs recorded.

Community analyses of NVO

More valuations

Run your own DCF · How accurate are these valuations?